Latest Nebulizer Stories
MIDLOTHIAN, Virginia, Nov. 12 /PRNewswire/ -- On Saturday, November 15, PARI Respiratory Equipment will be featured on the ABC Family show Today's Family, as part of their "Breathe Easier" series.
MONTEREY, Calif., Nov.
MIDLOTHIAN, Va., Oct. 28 /PRNewswire/ -- Today, PARI Respiratory Equipment presented a comparative study of three commercially available, breath-enhanced nebulizers and their in-vitro performance and delivery efficiency of budesonide inhalation suspension (Pulmicort Respules, AstraZeneca).
MIDLOTHIAN, Va., Oct.
Kamada, a biopharmaceutical company, has reported positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin delivered via an investigational eFlow Nebulizer System, in the treatment of cystic fibrosis.
Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow(R) Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis.
Transave, a biopharmaceutical company, has secured a $12.5 million venture loan from CIT Healthcare and Compass Horizon Funding Company, an affiliate of Horizon Technology Finance Management.
MONMOUTH JUNCTION, N.J., Oct.
Research and Markets (http://www.researchandmarkets.com/research/45fffb/delivering_drugs_b) has announced the addition of the "Delivering Drugs by Inhalation - Emerging Therapeutic Opportunities" report to their offering.
Teleflex Medical, a leading global supplier of disposable products for critical care and surgical applications, has received clearance from the FDA to market the Hudson RCI Neb-U-Mask(R), a respiratory device that allows for the concurrent delivery of aerosolized medication and a high concentration of medical gases to treat acute asthma exacerbations.